Cargando…
Lymphoma: imaging in the evaluation of residual masses
In the management of patients with lymphoma, imaging is essential not only for diagnosis but also to define prognosis and treatment by staging. Imaging is also used to assess the response to treatment that may affect the treatment strategy: new chemotherapeutic drug combinations and autologous stem...
Autores principales: | Rahmouni, A., Divine, M., Kriaa, S., Haïoun, C., Anglade, M.-C., Kobeiter, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554703/ http://dx.doi.org/10.1102/1470-7330.2002.0008 |
Ejemplares similares
-
MRI and PET of bone marrow in lymphoproliferative diseases
por: Rahmouni, A., et al.
Publicado: (2015) -
Whole-body diffusion-weighted imaging in lymphoma
por: Lin, C., et al.
Publicado: (2010) -
Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations
por: Rahmouni, Alain, et al.
Publicado: (2014) -
Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma
por: Lin, Chieh, et al.
Publicado: (2012) -
MRI features of intrahepatic extramedullary haematopoiesis in sickle cell anaemia
por: Jelali, Mohamed Ali, et al.
Publicado: (2006)